← Back to Company DatabaseVisit Website
Exscientia
AI-driven drug design and precision medicine for oncology.
PublicOxford, UKFounded 2012
About
Exscientia is a pharmatech company that combines AI with experimental biology to design and develop drugs faster and more effectively. The company was the first to put an AI-designed drug molecule into clinical trials. Its oncology pipeline includes precision medicine programs using patient-derived models for personalized treatment selection.
Total Funding
$550MKey Product
AI-driven drug discovery and precision medicine platformGeography
EuropeKey Investors
SoftBank Vision FundBlackRockBill & Melinda Gates Foundation
Focus Areas
Drug DiscoveryAI / Machine LearningTreatment (Therapeutics)
Technology
AI / Machine LearningTargeted Therapy
Cancer Types
Pan-cancerBlood Cancers
Last updated: Feb 4, 2026